#37 Beyond numbers: quality in ADR reporting ...

Send a message to the show!Pharmacovigilance has traditionally focused on the patient at the receiving end of a medicine. But what happens to medicines once they leave the body? In this episode, Valentina Giunchi and Joe Mitchell unpack the emerging field of ecopharmacovigilance ...  Show more

Send a message to the show!For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the Netherlands pharmacovigilance centre ...  Show more

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...

The high cost and complexity of specialty medications often contribute to adherence issues that negatively impact patient outcomes. Increasing adherence requires streamlined access to specialty medications and clear and frequent communication with patients to discuss dosage, freq ...  Show more

Getting solid answers in medicine can be hard — especially when the normal tools are off-limits. Dr. Bapu Jena discusses a research method that’s helping to solve some of science’s most challenging questions. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for infor ...  Show more

In this podcast, Dr Emma Nash talks to Professor Tony Avery, GP, Professor of Primary Health Care at the University of Nottingham, and National Clinical Director for Prescribing. Key points from the two prescribing safety modules are touched on, in the context of the Medicines Sa ...  Show more